Cargando…

Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication

OBJECTIVE: A prior longitudinal study demonstrates that free-water diffusion magnetic resonance imaging (dMRI) tracks progression in the substantia nigra (Ofori et al., 2015b). Here, we test the acute effects of antiparkinsonian medication on this established imaging progression marker for the first...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Jae Woo, Burciu, Roxana G., Ofori, Edward, Shukla, Priyank, Okun, Michael S., Hess, Christopher W., Vaillancourt, David E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328740/ https://www.ncbi.nlm.nih.gov/pubmed/28275542 http://dx.doi.org/10.1016/j.nicl.2017.02.012

Ejemplares similares

Beta-band oscillations in the supplementary motor cortex are modulated by levodopa and associated with functional activity in the basal ganglia
por: Chung, Jae Woo, et al.
Publicado: (2018)

Progression marker of Parkinson’s disease: a 4-year multi-site imaging study
por: Burciu, Roxana G, et al.
Publicado: (2017)

Imaging the lower limb network in Parkinson’s disease
por: Chung, Jae Woo, et al.
Publicado: (2023)

Imaging of Motor Cortex Physiology in Parkinson's Disease
por: Burciu, Roxana G., et al.
Publicado: (2018)

Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson’s disease
por: Taguchi, Soutarou, et al.
Publicado: (2021)

Antipsychotics dosage and antiparkinsonian prescriptions
por: Acquaviva, Eric, et al.
Publicado: (2007)

fMRI changes during multi-limb movements in Parkinson’s disease
por: Chung, Jae Woo, et al.
Publicado: (2023)

Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson’s Disease
por: SAMURA, Kazuhiro, et al.
Publicado: (2019)

Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011
por: Pitcher, T. L., et al.
Publicado: (2014)

Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs
por: Silva, Sara, et al.
Publicado: (2021)

A Method for Automated Classification of Parkinson’s Disease Diagnosis Using an Ensemble Average Propagator Template Brain Map Estimated from Diffusion MRI
por: Banerjee, Monami, et al.
Publicado: (2016)

Antiparkinsonian medication masks motor signal progression in de novo patients()
por: Brzezicki, Maksymilian A., et al.
Publicado: (2023)

A STUDY OF PROPHYLACTIC VALUE OF ANTIPARKINSONIAN DRUG
por: Behere, P.B., et al.
Publicado: (1983)

Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
por: Mitchell, Trina, et al.
Publicado: (2022)

Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder
por: Massari, Caio M., et al.
Publicado: (2017)

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems
por: Paccione, Nicola, et al.
Publicado: (2022)

Motor Improvement-Related Regional Cerebral Blood Flow Changes in Parkinson's Disease in Response to Antiparkinsonian Drugs
por: Taguchi, Soutarou, et al.
Publicado: (2019)

Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets
por: Michel, Anne, et al.
Publicado: (2017)

Free water imaging unravels unique patterns of longitudinal structural brain changes in Parkinson’s disease subtypes
por: Bower, Abigail E., et al.
Publicado: (2023)

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease
por: Quattrone, Andrea, et al.
Publicado: (2022)

The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate
por: Lieu, Christopher A., et al.
Publicado: (2012)

Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis
por: Nimmons, Danielle, et al.
Publicado: (2021)

Rate control deficits during pinch grip and ankle dorsiflexion in early-stage Parkinson’s disease
por: Chung, Jae Woo, et al.
Publicado: (2023)

Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling
por: Bonito-Oliva, Alessandra, et al.
Publicado: (2011)

Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
por: Miguelez, Cristina, et al.
Publicado: (2017)

Time until modification of antiparkinsonian therapy in a group of patients from Colombia
por: Valencia-Vásquez, Aníbal, et al.
Publicado: (2023)

Connectome analysis with diffusion MRI in idiopathic Parkinson's disease: Evaluation using multi-shell, multi-tissue, constrained spherical deconvolution
por: Kamagata, Koji, et al.
Publicado: (2017)

Rapid preparation process of antiparkinsonian drug Mucuna pruriens silver nanoparticle by bioreduction and their characterization
por: Arulkumar, Subramanian, et al.
Publicado: (2010)

1,5-Benzodiazepin-2(3H)-ones: In Vitro Evaluation as Antiparkinsonian Agents
por: Ortíz de Zárate, Ana, et al.
Publicado: (2021)

The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database
por: Johannes, Catherine B., et al.
Publicado: (2022)

Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson’s disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin
por: Guo, Chen-hong, et al.
Publicado: (2020)

c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism
por: Zhou, Yu, et al.
Publicado: (2018)

LUHMES Cells: Phenotype Refinement and Development of an MPP(+)-Based Test System for Screening Antiparkinsonian Drugs
por: Beliakov, Sergei V., et al.
Publicado: (2023)

Meningioma microstructure assessed by diffusion MRI: An investigation of the source of mean diffusivity and fractional anisotropy by quantitative histology
por: Brabec, Jan, et al.
Publicado: (2023)

Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's disease
por: Ofori, Edward, et al.
Publicado: (2019)

Diffusion MRI tractography for improved transcranial MRI-guided focused ultrasound thalamotomy targeting for essential tremor
por: Tian, Qiyuan, et al.
Publicado: (2018)

Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy
por: Talai, Aron S., et al.
Publicado: (2018)

Validation of deep learning techniques for quality augmentation in diffusion MRI for clinical studies
por: Aja-Fernández, Santiago, et al.
Publicado: (2023)

Intrasubject subcortical quantitative referencing to boost MRI sensitivity to Parkinson's disease
por: Khedher, Laila, et al.
Publicado: (2022)

Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study
por: Odish, Omar F.F., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6nqmkfu73ps648oq1s052ubtg6